June 2022 Quarterly Activity Report

22 Jul
Jul , 22 , 2022 Daniel Tillett
June-2022-Quarterly-Activity-ReportDownload
LinkedIn

Related posts:

Zantrene Protects Mouse Hearts from Chemotherapy Damage Race Receives Human Ethics Approval for Extramedullary AML & MDS Trial Appointment of Chief Financial Officer